Best surgical prophylaxis - risk-reducing mastectomy for women at high personal risk of breast cancer

Breast

Volumn 15, Issue SUPPL. 2, 2006, Pages

  Baildam, Andrew D ^a  

^a WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST AUGMENTATION; BREAST CANCER; BREAST RECONSTRUCTION; CANCER PREVENTION; CANCER RISK; CHROMOSOME 13; CHROMOSOME 17; CLINICAL EFFECTIVENESS; CONSULTATION; ESTHETICS; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; MASTECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK REDUCTION; SOCIAL PSYCHOLOGY; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAMMAPLASTY; MASTECTOMY; RISK FACTORS;

EID: 33947273012     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(07)70013-9     Document Type: Article

References (26)

1. Fisher B., Constantino J., Wickerham D., et al. Tamoxifen for prevention of breast cancer; report of the National Surgical Adjuvant Breast and Bowel Project PI study. J Natl Cancer Inst 90 (1998) 1371-1388
2. IBIS investigators. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360 (2002) 817-824
3. Newman B., Austin M., Lee M., et al. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci 85 (1988) 3044-3048
4. Claus E., Risch N., and Thompson W. Autosomal dominant inheritance of early onset breast cancer: implications for risk prediction. Cancer 73 (1994) 643-651
5. Miki Y., Swensen J., Shattuck-Eidens D., et al. A strong candidate for the breast and ovarian cancer gene BRCA1. Science 266 (1994) 66-71
6. Wooster R., Bignell G., Lancaster J., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378 (1995) 789-792
7. Malkin D., Li F., Strong L., et al. Germline TP53 mutations in cancer families. Science 250 (1990) 1233-1238
8. Parmigiani G., Berry D., and Aquilar O. Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62 (1998) 145-148
9. Berry D., Iversen Jr. E., Gudbjartsson D., et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20 (2002) 2701-2712
10. Lakhani S., Van De Vijver M., Jacquemier J., et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients. J Clin Oncol 20 (2002) 2310-2318
11. Vasen H., Haites N., Evans D., et al. Current policies for surveillance and management in women at risk of breast cancer: a survey among 16 European family cancer clinics. Eur J Cancer 34 (1998) 1922-1926
12. Evans D., and Lalloo F. Risk assessment and management of high risk familial breast cancer. J Med Genet 39 (2002) 865-871
13. Gail M., Brinton L., Byar D., et al. Projecting individualised probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81 (1989) 1879-1886
14. Tyrer J., Duffy S., and Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23 (2004) 1111-1130
15. Goodnight J., Quagliana J., and Morton D. Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol 26 (1984) 198-201
16. Zeigler L., and Kroll S. Primary breast cancer after prophylactic mastectomy. Am J Clin Oncol 14 (1991) 451-454
17. Hartmann L., Schaid D., Woods J., et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340 (1999) 77-84
18. Meijers-Heijboer E., van Geel B., van Putten W., et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345 (2001) 159-164
19. Eccles D., Evans D., and Mackay J. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. J Med Genet 37 (2000) 203-209
20. Eeles R. Testing for the breast cancer predisposition gene, BRCA 1. BMJ 313 (1996) 572-573
21. Evans D., Kerr B., Cade D., et al. Fictitious breast cancer family history. Lancet 348 (1996) 1034
22. Lalloo F., Baildam A., Brain A., et al. Preventative mastectomy for women at high risk of breast cancer. Eur J Surg Oncol 26 (2000) 711-713
23. Frost M., Schaid D., Sellers T., et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284 (2000) 319-324
24. Hatcher M., Fallowfield L., and A'Hern R. The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ 322 (2001) 76-79
25. Hopwood P., Lee A., Shenton A., et al. Clinical follow-up after bilateral risk reducing ('prophylactic') mastectomy: mental health and body image outcomes. Psychooncology 9 (2000) 462-472
26. Josephson U., Wickman M., and Sandelin K. Initial experiences of women from hereditary breast cancer families after bilateral prophylactic mastectomy: a retrospective study. Eur J Surg Oncol 26 (2000) 351-356